Estrogen receptor-&bgr; ligands
US6518301B1 · kind B1 · utility
35Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2002 |
| Grant date | Feb 11, 2003 |
| Priority date | — |
| Expiry date | Jan 7, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating a disease associated with the estrogen receptor-&bgr;, comprising the step of administering a therapeutically-effective amount of a compound that satisfies the equation: (Ki&agr;A/Ki&bgr;A)/(Ki&agr;E/Ki&bgr;E)>1, optionally having the general structure (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.